-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
January 01, 2009 - Background—In drug development, a four-phase hierarchical model for the clinical evaluation
of new pharmaceuticals … Analogous to the four-phase model for the evaluation of new drugs, these
models require that certain … Why have the phases in the clinical evaluation of drugs
become so well engrained in our thinking, and … The four phases in the development of drugs and devices have shown their merit. … Trials in humans take place only after drugs have been tested thoroughly in the
laboratory in animal
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/fibromyalgia-very-few-doctors-know-how-to-treat-this-pain-some-states-there-are-really-none-more-more-are-being-diagnosed-but-no-treatment-especially-with-severe-pain-fibro-brings-on-ibs-migrainesno-sleep-ect-a-lot-of-meds-ha
November 01, 2011 - no
If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/iron-deficiency-anemia-in-renal-dialysis-patients
June 17, 2008 - None
If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/can-anything-be-done-to-improve-diabetic-periphheral-neuropathywhat-is-truly-effective-what-research-seems-promising-diabetes-type-2well-controlled
April 02, 2013 - no
If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/health-topics/femur-neck
April 12, 2018 - Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention
Research Protocol
April 12, 2018
Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review
Systematic Review
April 23, 2019
-
effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
January 01, 2012 - Coordinating Council for Comparative Effectiveness Research,
AHRQ is interested in innovations in drugs … In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular level
(i.e., similar drugs in the … Tofacitinib (CP-690,550) in combination
with traditional disease-modifying anti-
rheumatic drugs:
-
effectivehealthcare.ahrq.gov/health-topics/quality-life
August 08, 2018 - Synthesizing Evidence for Quality Improvement
Abstract
August 8, 2018
Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention
Research Protocol
April 12, 2018
Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
January 30, 2014 - CNS Drugs. 2006;20(7):549-65. PMID: 16800715
41. Newcorn JH, Ivanov I. … BTA Pharmaceuticals Inc., Bridgewater, NJ
Bupropion Mylan Pharmaceuticals Inc., Morgantown, WV
Selective … New York, NY
Citalopram Teva Pharmaceuticals, Sellersville, PA
Escitalopram Teva Pharmaceuticals, Sellersville … , PA
Paroxetine Teva Pharmaceuticals, Sellersville, PA
Fluvoxamine Mylan Pharmaceuticals Inc., Morgantown … ") OR
SU.EXACT.EXPLODE("Adrenergic Drugs")) OR
(SU.EXACT.EXPLODE("Anticonvulsive Drugs") OR
SU.EXACT.EXPLODE
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy-executive-summary.pdf
May 01, 2023 - Two RCTs specifically evaluated end-organ
protective effects of two antihypertensive drugs in patients … Because the studies evaluated a large variety of specific drugs and evaluated disparate
outcomes, we … evidence related to maternal morbidity and
mortality (among two small studies that evaluated different drugs … Trials are needed for the numerous antihypertensive drugs commonly
used in practice to allow better
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-disposition-mental-health-pregnancy_0.pdf
June 01, 2021 - CNS drugs. 2017;31(6):439-450.
11. Pacchiarotti I, Leon-Caballero J, Murru A, et al. … First trimester exposure to anxiolytic and hypnotic drugs
and the risks of major congenital anomalies … Detoxification from
opiate drugs during pregnancy. … Atypical antipsychotic drugs and pregnancy
outcome: a prospective, cohort study. … Drugs. 2017;77(11):1211-1219.
56. Knickmeyer RC, Meltzer-Brody S, Woolson S, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
April 01, 2011 - Drugs that are
not approved by the FDA have been
removed. … Drugs that are
not approved by the FDA have been
removed. … Weiglein;
Takeda
Pharmaceuticals
North America,
Inc
Results 1. … Weiglein;
Takeda
Pharmaceuticals
North America,
Inc
Results 1. … Weiglein;
Takeda
Pharmaceuticals
North America,
Inc
Discussion 1.
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … after administration.35
Manufacturer and regulatory status: The drug was launched in 1966 by King
Pharmaceuticals … Drugs Future.
2009;34(3):217-21.
31. Research suggests new drug targets for
depression. … In: Drugs@FDA [internet]. Silver
Spring (MD): U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - Telaprevir
Telaprevir (Incivek™, Vertex Pharmaceuticals, Inc., Cambridge, MA) is orally administered … Optimer Pharmaceuticals announced a 2-year
agreement with Cubist Pharmaceuticals, Inc. … Tibotec Pharmaceuticals, Vertex
Pharmaceuticals. … Berlin: Vertex Pharmaceuticals; 2011 Mar 31
[accessed 2011 May 17]. [4 p]. … (FDA
briefing document for Anti-Infective Drugs
Advisory committee meeting).
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
January 01, 2020 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Along with access to relatively inexpensive illicit opioid drugs, such as heroin, and
increased use … Available:
http://www.accessdata.fda.gov/scripts/cder/drugs
atfda/index.cfm? … For drugs that save lives, a steep
cost. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
January 01, 2006 - Common oral medications for
osteoarthritis include nonsteroidal
antiinflammatory drugs (NSAIDs) and
acetaminophen … Food and Drug
Administration (FDA) as pharmaceuticals,
including glucosamine and chondroitin, as
well … In addition,
efficacy and safety may vary for individual
drugs within a class. … For this report, we defined the terms “selective
NSAIDs” or “COX-2 selective NSAIDs” as drugs in
the … We defined “partially selective
NSAIDs” as other drugs shown to have partial in vitro
COX-2 selectivity
-
effectivehealthcare.ahrq.gov/products/nsaids-safety-data-mining/research
December 02, 2009 - who were exposed to cyclooxygenase selective (coxib) or nonselective nonsteroidal anti-inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
January 01, 2011 - These approval
documents—which can be found at Drugs@FDA.gov—may help identify publication bias even … Ottawa: Canadian Agency for
Drugs and Technologies in Health; 2008.
46. … Ottawa: Canadian Agency for Drugs
and Technologies in Health. … an
pharmaceuticals, more non-U.S. coverage than
MEDLINE
Avenell, 2001
Minozzi, 2000
Sampson, … and pharmaceuticals Fishman, 1996
Wolfe, 2002
MANTIS
(Manual Alternative and Natural
Therapy Index
-
effectivehealthcare.ahrq.gov/products/machine-learning/research
September 07, 2012 - decisions from a 2006 comparative effectiveness review of off-label uses of atypical anti-psychotic drugs
-
effectivehealthcare.ahrq.gov/products/mental-illness-employment/abstract
December 20, 2011 - patterns of medical and mental health care and patient-reported functional status, use of alcohol and drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
January 01, 2011 - PICO
Population(s): Adult patients with PAD and comorbid or multimorbid disease
Intervention(s): Drugs